Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.6), the stock would be worth ₫66 357.95 (48% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.9 | ₫126 500 |
0%
|
| 3-Year Average | 2.6 | ₫66 357.95 |
-48%
|
| 5-Year Average | 1.7 | ₫44 674.87 |
-65%
|
| Industry Average | 2.2 | ₫57 905.84 |
-54%
|
| Country Average | 1.7 | ₫43 551.32 |
-66%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| VN |
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
1.2T VND | 4.9 | 19.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
820.3B USD | 30.9 | 39.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
542.6B USD | 6.7 | 25.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 7.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.7B GBP | 5.9 | 28.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.2B CHF | 5.9 | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.8B USD | 5.2 | 14.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -58.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 6 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.3B USD | 1.8 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.3B USD | 6.3 | 16.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 1.3 |
| Median | 1.7 |
| 70th Percentile | 2.2 |
| Max | 16.4 |
Other Multiples
Pharmedic Pharmaceutical Medicinal JSC
Glance View
Pharmedic Pharmaceutical Medicinal JCSC engages in the production and distribution of drugs, medicinals, cosmetics, medical materials and other medical related items. The company is headquartered in Ho Chi Minh, Ho Chi Minh. The company went IPO on 2009-10-09. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
